A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Patients' own stem cells to replace damaged dopamine cells in Parkinson’s disease, offering new hope. Parkinson's disease - ...

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway ...

NEW ORLEANS, March 11, 2025 /PRNewswire/ -- A pioneering Phase 1 clinical trial, reported in a March 9, 2025, ScienceDaily article, is advancing stem cell therapies for Parkinson's disease.

Brain Mapping Breakthrough Offers New Insights into Alzheimer's DiseaseResearchers from The University of Texas at Arlington ...

Greg Cipes, whose distinctive California surfer-style vocals have brought the green-skinned shapeshifter Beast Boy to life ...

A team of scientists has revealed a breakthrough discovery, linking genetic variants in the gene ITSN1 to a significantly el ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

A mother has banked her newborn's umbilical cord stem cells after her colleague died from leukaemia. Natalie Harrop, from Newport, was prompted to take this step after the death of a work colleague ...